Edmund Dunn, Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 139 shares at $17.96 ($2K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Open-market sale of $2k GLUE by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2025-06-04 | $9K | — | Filing → |
| GLUE | SELL | 2024-07-09 | $6K | — | Filing → |
| GLUE | SELL | 2024-06-05 | $5K | — | Filing → |